Table 1. Characteristics of Participants With Symptoms (n = 220 588) by SARS-CoV-2 and Venous Thromboembolism (VTE) Status.
| Characteristic | Patients, No. (%) | |||
|---|---|---|---|---|
| SARS-CoV-2 positive | SARS-CoV-2 negative | |||
| No VTE (n = 25 906) | VTE (n = 198) | No VTE (n = 193 476) | VTE (n = 1008) | |
| Age, y | ||||
| 18-29 | 5925 (23) | 14 (7) | 34 180 (18) | 28 (3) |
| 30-39 | 5670 (22) | 19 (10) | 41 102 (21) | 47 (5) |
| 40-49 | 5451 (21) | 38 (19) | 36 432 (19) | 89 (9) |
| 50-59 | 4682 (18) | 48 (24) | 33 676 (17) | 152 (15) |
| 60-69 | 2655 (10) | 40 (20) | 25 593 (13) | 245 (24) |
| 70-79 | 984 (4) | 26 (13) | 14 382 (7) | 234 (23) |
| ≥80 | 539 (2) | 13 (7) | 8111 (4) | 213 (21) |
| Median (IQR) | 42 (31-55) | 56 (45-67) | 46 (34-60) | 68 (56-78) |
| Sex | ||||
| Women | 13 649 (53) | 79 (40) | 116 837 (60) | 510 (51) |
| Men | 12 257 (47) | 119 (60) | 76 639 (40) | 498 (49) |
| Race/ethnicity | ||||
| Asian | 3176 (12) | 30 (15) | 32 310 (17) | 116 (12) |
| Black | 1767 (7) | 25 (13) | 13 857 (7) | 105 (10) |
| Hispanic | 13 116 (51) | 88 (44) | 46 857 (24) | 127 (13) |
| White | 5667 (22) | 45 (23) | 84 398 (44) | 615 (61) |
| Missing/other | 2180 (8) | 10 (5) | 16 054 (8) | 45 (4) |
| BMI | ||||
| Underweight | 163 (1) | 1 (0) | 2616 (1) | 24 (2) |
| Healthy weight | 4588 (18) | 23 (12) | 55 413 (29) | 256 (25) |
| Overweight | 7963 (31) | 56 (28) | 62 134 (32) | 303 (30) |
| Obese | 12 086 (47) | 110 (56) | 69 244 (36) | 417 (41) |
| Unknown | 1106 (4) | 8 (4) | 4069 (2) | 8 (1) |
| Median (IQR) | 30 (26-34) | 31 (28-36) | 28 (24-32) | 29 (24-34) |
| Comorbidities | ||||
| Hypertension | 2563 (10) | 98 (49) | 25 151 (13) | 611 (61) |
| Diabetes | 2672 (10) | 71 (36) | 18 493 (10) | 322 (32) |
| Chronic kidney disease | 901 (3) | 28 (14) | 11 056 (6) | 273 (27) |
| COPD/asthma | 2254 (9) | 38 (19) | 28 058 (15) | 300 (30) |
| Congestive heart failure | 364 (1) | 22 (11) | 6128 (3) | 256 (25) |
| Liver cirrhosis | 69 (0) | 3 (2) | 1029 (1) | 38 (4) |
| Malignant neoplasm | 397 (2) | 15 (8) | 8592 (4) | 298 (30) |
| Charlson Comorbidity Index score | ||||
| 0 | 18 428 (71) | 96 (48) | 122 256 (63) | 264 (26) |
| 1-2 | 5698 (22) | 66 (33) | 48 548 (25) | 271 (27) |
| 3-4 | 986 (4) | 16 (8) | 11 429 (6) | 193 (19) |
| ≥5 | 794 (3) | 20 (10) | 11 243 (6) | 280 (28) |
| Median (IQR) | 0 (0-1) | 1 (0-2) | 0 (0-1) | 2 (0-5) |
| Smoking status | ||||
| Ever | 6597 (25) | 58 (29) | 66 075 (34) | 491 (49) |
| Never | 18 367 (71) | 131 (66) | 124 209 (64) | 510 (51) |
| Unknown | 942 (4) | 9 (5) | 3192 (2) | 7 (1) |
| Test month | ||||
| February-April | 2068 (8) | 46 (23) | 28 428 (15) | 201 (20) |
| May | 979 (4) | 9 (5) | 32 579 (17) | 235 (23) |
| June | 3354 (13) | 25 (13) | 28 577 (15) | 165 (16) |
| July | 12 185 (47) | 70 (35) | 61 153 (32) | 217 (22) |
| August | 7320 (28) | 48 (24) | 42 739 (22) | 190 (19) |
| Laboratory test setting | ||||
| Outpatient | 22 209 (86) | 95 (48) | 168 780 (87) | 190 (19) |
| Emergency department | 2420 (9) | 22 (11) | 12 997 (7) | 107 (11) |
| Inpatient | 1277 (5) | 81 (41) | 11 699 (6) | 711 (71) |
| Highest level of follow-up care | ||||
| Outpatient/emergency department | 23 092 (89) | 28 (14) | 172 713 (89) | 114 (11) |
| Inpatient | 2252 (9) | 82 (41) | 18 479 (10) | 645 (64) |
| Intensive care unit | 562 (2) | 88 (44) | 2284 (1) | 249 (25) |
Abbreviations: BMI, body mass index calculated as weight in kilograms divided by height in meters squared; COPD, chronic obstructive pulmonary disease; IQR, interquartile range.